A 24-Week Treatment Strategy With Pegylated Interferon/Ribavirin in HIV/Hepatitis C Virus Genotype 3-Coinfected Patients Who Achieved a Rapid Virologic Response Results in a High Sustained Virologic Response Rate

作者：Rivero Juarez Antonio; Lopez Cortes Luis F; Camacho Angela; Mira Jose A; Tellez Francisco; Marquez Manuel; Merino Dolores; Pineda Juan A; Rivero Antonio^*

来源：Clinical Infectious Diseases, 2014, 58(1): 130-133.

DOI：10.1093/cid/cit653

• HIV
• HCV
• genotype 3
• RVR
• 24 weeks

We designed a study to evaluate the efficacy of a 24-week treatment strategy in HIV/hepatitis C virus (HCV) genotype 3-coinfected patients achieving rapid virologic response for a first HCV treatment with pegylated interferon plus ribavirin (peg-IFN/RBV). Our results suggest that a shorter course of peg-IFN/RBV therapy may be sufficient in this population.

• 出版日期2014-1-1